93 results on '"Rogers, A. D."'
Search Results
2. Tu1349: AUTOIMMUNE QUESTIONNAIRE AND SYMPTOMS, GASTRIC EMPTYING, AUTONOMIC NERVOUS SYSTEM AND ENTERIC NERVOUS SYSTEM IN PATIENTS WITH THE SYMPTOMS OF GASTROPARESIS
3. Sa1476: FULL THICKNESS GASTRIC BIOPSIES IN PATIENTS WITH THE SYMPTOMS OF GASTROPARESIS:ANALYSIS OF 228 PATIENTS
4. Mo1174: NOVEL ARTIFICIAL INTELLIGENCE PROGRAM USING CONVOLUTIONAL NEURAL NETWORK IDENTIFIES SUPRAGASTRIC BELCHING ON PHIMPEDANCE STUDIES
5. Sa1478: RESPONSE TO BOTULINUM TOXIN IN PYLORIC SPHINCTER USING FLIP IN PATIENTS WITH GASTROPARESIS SYMPTOMS CORRESPONDS TO BASELINE PHYSIOLOGIC FINDINGS
6. Mo1187: INTERMITTENT HIATUS HERNIA ON HIGH RESOLUTION MANOMETRY HAS REFLUX BURDEN IDENTICAL TO PERSISTENT HIATUS HERNIA
7. Su1371: CORRELATION BETWEEN ANATOMIC, PHYSIOLOGIC AND IMFLAMMATORY MARKERS IN PATIENTS WITH GASTROPARESIS AND NASH/NAFLD
8. Sa1201: CHRONIC OPIOID USERS WITH DYSPHAGIA ARE INDISTINGUISHABLE FROM SYMPTOMATIC NON-OPIOID USERS ON FUNCTIONAL LUMEN IMAGING PROBE EVALUATION
9. 7: PROXIMAL GASTRIC PRESSURIZATION FOLLOWING SLEEVE GASTRECTOMY PREDICTS GASTROESOPHAGEAL REFLUX
10. EP1124: IN NERD PATIENTS WITH SIMILAR ACID BURDEN, THE PRESENCE OF HIATAL HERNIA INDEPENDENTLY IMPAIRED DISTAL ESOPHAGEAL MUCOSAL INTEGRITY, PRESUMABLY THROUGH EXCESSIVE BILE REFLUX
11. Sa1477: ROLE OF INTRAVENOUS IMMUNOGLOBULIN IN TREATMENT OF DRUG REFRACTORY GASTROPARESIS
12. Mo1176: GASTROESOPHAGEAL REFLUX DISEASE (GERD) SYMPTOMS INCREASE FOLLOWING SLEEVE GASTRECTOMY DESPITE TRIAGE OF PATIENTS WITH GERD TO ROUX-EN-Y GASTRIC BYPASS
13. Su1418: GASTRO-PYLORIC FUNCTION IN GASTROPARESIS UTILIZING FLIP
14. Tu1244 CHRONIC OPIATE USERS DEMONSTRATE OBSTRUCTIVE FEATURES ON FUNCTIONAL LUMEN IMAGING PROBE DESPITE NORMAL MOTILITY OR INEFFECTIVE ESOPHAGEAL MOTILITY ON HIGH RESOLUTION MANOMETRY
15. Mo1661 CLINICAL USEFULNESS OF PYLORIC FLIP IN PATIENTS WITH THE SYMPTOMS OF GASTROPARESIS AND NO PREVIOUS INTERVENTIONS—SINGLE CENTER LONG-TERM FOLLOW-UP
16. Mo1649 CLINICAL USEFULNESS OF PYLORIC FLIP WITH BOTULINUM TOXIN IN PATIENTS WITH THE SYMPTOMS OF GASTROPARESIS AND WITH PREVIOUS INTERVENTIONS—SINGLE CENTER LONG-TERM FOLLOW-UP
17. Mo1293 PH IMPEDANCE MONITORING ON PROTON PUMP INHIBITOR THERAPY IN UNPROVEN GERD DOES NOT IMPACT DECISIONS REGARDING FURTHER ACID SUPPRESSION BUT CAN IDENTIFY REFRACTORY GERD IN PROVEN GERD PATIENTS
18. Mo1294 PRIMARY PERISTALSIS IS THE DOMINANT MECHANISM OF PH RECOVERY FOLLOWING GASTROESOPHAGEAL REFLUX REGARDLESS OF TIMING AFTER REFLUX
19. Su2039 A CENTRALIZED INTERPRETATION OF DE-IDENTIFIED PEDIATRIC HIGH-RESOLUTION MANOMETRY STUDIES FROM A MULTICENTER COHORT: CHICAGO CLASSIFICATION V4.0 PROTOCOL IS OFTEN NOT FOLLOWED, BUT DIAGNOSIS CHANGES ARE MOSTLY NON-ACTIONABLE
20. 165 MANOMETRIC SCREENING USING THE NOVEL MILAN SCORE IDENTIFIES LIKELIHOOD OF OBJECTIVE GASTROESOPHAGEAL REFLUX IN PATIENTS WITH LARYNGOPHARYNGEAL REFLUX SYMPTOMS
21. 166 EXTERNAL VALIDATION DEMONSTRATES HIGH PREDICTIVE VALUE OF THE LYON SCORE: A NOVEL REFLUX SCORING SYSTEM BASED ON THE LYON CONSENSUS 2.0
22. Su196 THE CLINICAL VALUE OF PSYCHOLOGICAL INTERVENTIONS IN FUNCTIONAL FOREGUT SYMPTOMS
23. Sa395 THE USE OF PYLORIC IMPEDANCE PLANIMETRY IN GASTROPARESIS
24. Su206 INCOMPLETE HIGH RESOLUTION MANOMETRY STUDIES: PREVALENCE AND PREDICTIVE FACTORS
25. Sa152 THRESHOLDS FOR REFLUX METRICS ON PH-IMPEDANCE MONITORING PERFORMED 'ON’ BID PROTON PUMP INHIBITOR (PPI) THERAPY: MULTICENTER INTERNATIONAL COLLABORATIVE STUDY
26. Su182 BREAKS IN PERISTALTIC INTEGRITY PREDICT ABNORMAL ESOPHAGEAL BOLUS CLEARANCE BETTER THAN CONTRACTION VIGOR OR INTEGRATED RESIDUAL PRESSURE IN HEALTHY VOLUNTEERS
27. Sa151 ARTIFICIAL INTELLIGENCE AUTOMATES IDENTIFICATION OF SUPRAGASTRIC BELCHING WITH ACCURACY COMPARATIVE TO EXPERT MANUAL REVIEW
28. Sa401 BASELINE FACTORS COMBINED WITH TEMPORARY TRIAL CAN PREDICT LONG TERM OUTCOME WITH GASTRIC ELECTRICAL STIMULATION
29. Mo2002 INEFFECTIVE ESOPHAGEAL MOTILITY: CHARACTERIZATION AND OUTCOMES ACROSS PEDIATRIC NEUROGASTROENTEROLOGY AND MOTILITY CENTERS IN THE US
30. Mo1304 NATURAL HISTORY OF NON-ACHALASIA ESOPHAGEAL MOTOR DISORDERS: A 15-YEAR FOLLOW-UP STUDY
31. Mo1276 EHLERS DANLOS SYNDROME: ESOPHAGEAL MANIFESTATIONS AND HIGH RESOLUTION MANOMETRY FINDINGS
32. Su1306 DO TEMPORARY AND PERMANENT GASTRIC ELECTRICAL STIMULATION CHANGE GERD SYMPTOMS IN PATIENTS WITH GASTROPARESIS SYNDROMES?
33. Su1643 ANATOMIC ANALYSIS AND PYLORIC FUNCTIONAL LUMINAL IMAGING PROBE (PFLIP) IN PATIENTS WITH GASTROPARESIS SYMPTOMS TO GUIDE THERAPY IN DRUG-RESISTANT GASTROPARESIS
34. Sa1245 FULL THICKNESS BIOPSY IN GASTROPARESIS SYNDROME PATIENTS UNDERGOING GASTRIC ELECTRICAL STIMULATION CORRELATES WITH ONE YEAR SYMPTOM OUTCOME
35. 1218 IDENTIFICATION OF OBSTRUCTIVE PHENOTYPES WITHIN ABSENT CONTRACTILITY ON ESOPHAGEAL HIGH-RESOLUTION MANOMETRY
36. Sa1211 ESOPHAGEAL REFLUX HYPERSENSITIVITY: IDENTIFICATION OF DIFFERENT PHENOTYPES WITH POTENTIAL TREATMENT IMPLICATIONS
37. 526 AUTOMATED TEXT MESSAGE ALGORITHM REDUCES COLONOSCOPY NO SHOW RATES AND FAILED PROCEDURES IN A VA SETTING (POSTER PRESENTATION)
38. Tu1421 ESOPHAGOGASTRIC JUNCTION MORPHOLOGY AND CONTRACTILE INTEGRAL ON HIGH-RESOLUTION MANOMETRY IN ASYMPTOMATIC HEALTHY VOLUNTEERS AND SYMPTOMATIC INDIVIDUALS: AN INTERNATIONAL MULTICENTER STUDY
39. Tu1400 ABSENCE OF CONTRACTION RESERVE IN SEVERE INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) ASSOCIATES WITH HIGHER GERD SYMPTOMS BUT NOT DYSPHAGIA ON VALIDATED PATIENT-REPORTED OUTCOMES QUESTIONNAIRES
40. 12 NORMALIZATION OF NUMBER OF REFLUX EPISODES ON PH-IMPEDANCE MONITORING ASSOCIATES WITH IMPROVED SYMPTOM OUTCOME AND TREATMENT SATISFACTION IN GASTROESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS WITH REGURGITATION
41. 149 ARTIFICIAL INTELLIGENCE AUTOMATES EVALUATION OF BASELINE IMPEDANCE FROM PH-IMPEDANCE STUDIES AND PREDICTS SYMPTOM OUTCOME IN GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD)
42. 139 PREVALENCE OF MAJOR AND MINOR MOTOR DISORDERS ON HIGH-RESOLUTION MANOMETRY (HRM) IN ASYMPTOMATIC INDIVIDUALS: AN INTERNATIONAL MULTICENTER STUDY
43. Tu1399 HIGH PROPORTIONS OF OBSTRUCTIVE PHENOTYPES WITHIN ABSENT CONTRACTILITY ON HIGH-RESOLUTION MANOMETRY (HRM): VALUE OF ADJUNCTIVE TESTING
44. 485 Duodenal Spectral Markers for Field Carcinogenesis Detection of Pancreatic Cancer: Implications for Interductal Papillary Mucinous Neoplasia (IPMNs) Diagnosis and Management
45. 652 Microvascular Biomarkers in the Endoscopically Normal Rectal Mucosa for Colon Neoplasia Risk Stratification: Results of a Training/Validation Dataset
46. Tu1182 Development of a Novel Biophotonic Assay for Colonic Field Carcinogenesis Detection: Implications for Colorectal Cancer Risk Stratification
47. 1133 Development and Clinical Performance of a Novel Low Coherence Enhanced Backscattering Spectroscopy (LEBS) Fiberoptic Probe for Duodenal Sensing of Pancreatic Cancer Risk
48. 545 In Situ Rectal Spectral Markers for Colonic Neoplasia Risk Stratification-a Blinded Validation Study
49. in Situ Low Coherence Enhanced Backscattering Spectroscopy (LEBS) for Risk-Stratification of Colon Carcinogenesis: Implications for Screening and Surveillance.
50. Improving Fecal Colorectal Cancer (CRC) Screening Tests by Field Carcinogenesis Detection From Fecal Colonocytes via Partial Wave Spectroscopic (PWS) Nanocytology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.